MondayJun 13, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) and the Budding Alternative Nicotine Market

The nicotine pouch market is projected to reach $21.84 billion in 2027, up from $2.33 billion in 2020, representing a CAGR of 30.7% The smokeless tobacco products sector is expected to post a CAGR of 7.2% over the forecast period (2018-2025) Lexaria, through its patented DehydraTECH technology, is tapping into this important alternative nicotine sector  Its management is confident that its research and technology development investment will pay off and provide greater consumer satisfaction. In 2019, it was estimated that at least 1.1 billion people globally smoked cigarettes regularly. 780 million, representing 71% of the global smoking population, noted that…

Continue Reading

WednesdayJun 08, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Adding to Cannabis Product Line, Research

Flora Growth is building on its cannabis brand globalization efforts with two partnerships that expand its product portfolio and its research efforts in the United States and United Kingdom Flora’s partnership with former NFL athlete Ricky Williams has delivered its first product — a cannabis one-hitter accessory designed to provide a unique experience emblematic of Williams’ active lifestyle brand The company’s acquisition of the Masaya CBD brand developed by a cell biologist on Flora’s board of directors gives the company a formulation suitable for its current clinical trial efforts in the United Kingdom, and a well-received brand designed to help…

Continue Reading

MondayJun 06, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Bolsters its Global Expansion Strategy with Cannabis Regulatory Veteran Holly Bell’s Appointment; Hosts Regulatory Webinar

Flora Growth has appointed regulatory veteran Holly Bell as the new Vice President of Regulatory Affairs Bell will help further the company’s domestic and global expansion strategy and lead government relations in key international markets She will also oversee the regulatory strategy supporting the advancement of the company’s cultivation, distribution, and pharmaceutical programs Bell also participated in the first event in her new position- the Florida Industrial Hemp Conference and Exhibition held on May 20-22, 2022 In recent months, Flora Growth (NASDAQ: FLGC) has been on an aggressive international expansion plan that has seen exports to Mexico and Spain, with…

Continue Reading

FridayJun 03, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better

Lexaria Bioscience is a global innovator in drug delivery platforms, developing a technology designed to improve the performance of other medicinal products by making them more rapidly and effectively usable by patients’ bodies Lexaria’s patented DehydraTECH technology has been studied in combination with a number of other products, including but not limited to, cannabidiol (“CBD”), oral nicotine, antivirals, NSAIDs, and erectile dysfunction therapies The company is pursuing FDA approval under the Investigational New Drug (“IND”) process to clinically test its DehydraTECH-CBD for the treatment of high blood pressure A driving focus of the company’s R&D has been to improve the…

Continue Reading

WednesdayJun 01, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Consistently Enhancing the Oral Administration of Active Pharmaceutical Ingredients

A global innovator in drug delivery platforms, Lexaria has developed a patented technology, DehydraTECH(TM)  Through research, Lexaria has evidenced that DehydraTECH enhances the efficiency and speed of orally- administered fat-soluble active pharmaceutical ingredients (“APIs”) Lexaria is consistently enhancing the delivery of APIs that affect current oral formulations: speed of onset, limited absorption, and low membrane permeability Lexaria has conducted numerous ground-breaking studies, some of which open up the possibility of fast-acting oral products that avoid the lung diseases and cancers caused by inhalation of combusted molecules common in smoking Oral formulations account for approximately 90% of the global share of…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977